Histone deacetylase 3 inhibition alleviates 2,4-dinitrochlorobenzene-induced atopic dermatitis via epigenetically upregulating Nrf2/HO-1 signaling pathway
- 21 November 2023
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 126, 111107
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation Project of Chongqing (cstc2020jcyj-bshX0110)
This publication has 27 references indexed in Scilit:
- HDAC3 Mediates the Inflammatory Response and LPS Tolerance in Human Monocytes and MacrophagesFrontiers in Immunology, 2020
- Dichotomous engagement of HDAC3 activity governs inflammatory responsesNature, 2020
- Chijabyukpi-Tang Inhibits Pro-Inflammatory Cytokines and Chemokines via the Nrf2/HO-1 Signaling Pathway in TNF-α/IFN-γ-Stimulated HaCaT Cells and Ameliorates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis-Like Skin Lesions in MiceFrontiers in Pharmacology, 2020
- HDAC3 Regulates Gingival Fibroblast Inflammatory Responses in PeriodontitisJournal of Dental Research, 2019
- HDAC3 inhibition in diabetic mice may activate Nrf2 preventing diabetes-induced liver damage and FGF21 synthesis and secretion leading to aortic protectionAmerican Journal of Physiology-Endocrinology and Metabolism, 2018
- Epicutaneous Sensitization in Patients with Atopic DermatitisPediatric Allergy, Immunology, and Pulmonology, 2016
- Anti‐inflammatory therapies in atopic dermatitisAllergy, 2016
- Nrf2 deficiency causes lipid oxidation, inflammation, and matrix-protease expression in DHA-supplemented and UVA-irradiated skin fibroblastsFree Radical Biology and Medicine, 2015
- Cytokines and T cells in atopic dermatitisEuropean Cytokine Network, 2013
- Atopic dermatitisThe Lancet, 2003